Drug Search Results

Dropropizine

Alternative Names: dropropizine
Latest Update: 2024-05-05
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Ache Labs
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dropropizine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Rhinitis|Inflammation|Common Cold

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
ACH-NTS-03(02/10)	P3	Withdrawn	Inflammation\|Common Cold\|Rhinitis	2012-04-01

Recent News Events

Date	Type	Title
05/05/2024	PubMed	Green and inventive fluorescence approach for levodropropizine determination in human plasma.
03/15/2024	PubMed	Eco-friendly novel deconvoluted synchronous spectrofluorimetric approach for the determination of favipiravir, levodropropizine and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in laboratory prepared mixtures and spiked human plasma.
09/19/2022	PubMed	Effectiveness and Safety of Codeine and Levodropropizine in Patients With Chronic Cough.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions